Centiva Capital’s Teladoc Health TDOC Stock Holding History

Centiva Capital’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,500	Closed	-$397K	–	1977
2022 Q1	$397K	Sell	5,500 -6,000	-52%	-$432K	0.01%	1077
2021 Q4	$1.06M	Buy	11,500 +10,000	+667%	+$1.2M	0.02%	588
2021 Q3	$190K	Sell	1,500 -17,000	-92%	-$2.48M	0.01%	943
2021 Q2	$3.08M	Buy	18,500 +7,500	+68%	+$1.22M	0.07%	216
2021 Q1	$2M	Buy	11,000 +8,000	+267%	+$1.86M	0.08%	195
2020 Q4	$600K	Buy	+3,000	New	+$610K	0.02%	401
2019 Q4	–	Sell	-900	Closed	-$61K	–	925
2019 Q3	$61K	Buy	+900	New	+$59.2K	﹤0.01%	574

Other funds holding TDOC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Centiva Capital's TDOC Position: Q1 2026 in Review

Centiva Capital held its Teladoc Health (TDOC) position steady in Q1 2026 at 20,000 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #1374.

Centiva Capital first reported a position in TDOC in Q3 2019 and has held it in 14 quarters since. The position peaked at $5.72M in Q3 2021. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

Centiva Capital held 20,000 shares of Teladoc Health worth $109K as of Q1 2026.
Centiva Capital left its Teladoc Health share count unchanged in Q1 2026.
Teladoc Health made up ﹤0.01% of Centiva Capital's portfolio in Q1 2026, its #1374 holding.
Centiva Capital first reported a position in Teladoc Health in Q3 2019 and has held it in 14 quarters since.
Centiva Capital's Teladoc Health position peaked at $5.72M in Q3 2021.
323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.